图书简介
Bridges the gap between the chemistry of small molecule neuromodulators and the complex pattern of neurodegenerative disorders Written by an experienced neurochemist, this book focuses on the main actors involved in neurodegenerative disorders at a molecular level, and places special emphasis on structural aspects and modes of action. Drawing on recent data on enzyme structure, mode of action, and inhibitor design, it describes?from a biochemical point of view?the six most important neurotransmitter systems and their constituent enzymes and receptors. Misfolding and aggregation of proteins within the brain is also covered. In addition, the book surveys a wide range of proven and prospective therapeutic agents that modulate key processes in the brain, from their chemical synthesis to their mode of action in model systems as well as in the patient. Chemical Biology of Neurodegeneration: A Molecular Approach is presented in two parts. The first introduces the neurotransmitter systems and provides a general explanation of the synapse and a description of the main structures involved in neurotransmission that can be considered therapeutic targets for disorders of the central nervous system. The second part presents molecular and chemical aspects directly involved or affected in neurodegeneration, including the metabolism of neurotransmitters, enzymes processing neurotransmitters, protein misfolding, and therapeutic agents. -Uses an interdisciplinary approach to bridge the gap between the basic biochemical events in a nerve cell and their neurological effects on the brain -Places emphasis on the chemistry of small molecule modulators that are potential lead molecules for new drugs -Covers six key neurotransmitter systems and their enzymes and receptors?dopaminergic, noradrenergic, serotonergic, cholinergic, GABAergic, and glutamatergic Chemical Biology of Neurodegeneration: A Molecular Approach is a key resource for medicinal chemists, neurobiologists, neurochemists, biochemists, molecular biologists, and neurophysiologists.
Preface xi Part I Neurotransmitter Systems 1 1 The Dopaminergic System 3 1.1 Introduction 3 1.2 Dopamine Receptors 5 1.2.1 Classification 5 1.2.2 Location 5 1.2.3 General Structural Considerations 6 1.2.4 Effector Mechanisms 8 1.2.5 Implication in Neurodisorders 9 1.2.6 D1?like Receptors 9 1.2.7 D2?like Receptors 12 1.3 Vesicular Monoamine Transporter (VMAT) 18 1.4 The Dopamine Transporter (DAT) 21 1.4.1 Structural Aspects 21 1.4.2 Molecular Mechanism 24 References 26 2 The Noradrenergic System 41 2.1 Introduction 41 2.2 Adrenoreceptors 43 2.2.1 Classification 43 2.2.2 Location 44 2.2.3 General Structure Considerations 44 2.2.4 Effector Mechanisms 44 2.2.5 Implication in Neurodisorders 45 2.2.6 1?Adrenoreceptors 46 2.2.7 2?Adrenoreceptors 48 2.2.8 ?Adrenoreceptors 49 2.3 Neuropeptides Receptors 58 2.3.1 Neuropeptide Y Receptors 58 2.3.2 Galanin Receptors 61 2.4 Norepinephrine Transporter (NET) 63 References 65 3 The Serotonergic System 81 3.1 Introduction 81 3.2 Serotonin Receptors 83 3.2.1 Classification 83 3.2.2 Location 86 3.2.3 General Structural Considerations 86 3.2.4 Effector Mechanism 87 3.2.5 Implication in Neurodisorders 88 3.2.6 5?HT1 Receptors 89 3.2.7 5?HT2 Receptors 92 3.2.8 5?HT3 Receptors 96 3.2.9 5?HT4 Receptors 98 3.2.10 5?HT5 Receptors 98 3.2.11 5?HT6 Receptors 100 3.2.12 5?HT7 Receptors 101 3.3 Serotonin Reuptake Transporter (SERT) 102 References 107 4 The Cholinergic System 121 4.1 Introduction 121 4.2 Cholinergic Receptors 123 4.2.1 Classification 123 4.2.2 Location 124 4.2.3 Nicotinic Receptors 125 4.2.3.1 Effector Mechanisms 125 4.2.3.2 Implication in Neurodisorders 126 4.2.3.3 Structure of Subunits 126 4.2.3.4 Structure of Receptors 126 4.2.4 Muscarinic Receptors 132 4.2.4.1 Effector Mechanisms 133 4.2.4.2 Implication in Neurodisorders 134 4.2.4.3 M1 Receptor 134 4.2.4.4 M2 Receptor 135 4.2.4.5 M3 Receptor 135 4.2.4.6 M4 Receptor 139 4.2.4.7 M5 Receptor 141 4.3 Cholinergic Transporters 141 4.3.1 Vesicular Acetylcholine Transporter (VAChT) 141 4.3.2 High?Affinity Choline Transporter (ChT) 143 References 145 5 The Glutamatergic System 155 5.1 Introduction 155 5.2 Glutamate Receptors 157 5.2.1 Classification 157 5.2.2 Ionotropic Receptors 159 5.2.2.1 Location 159 5.2.2.2 Effector Mechanisms 161 5.2.2.3 Implication in Neurodisorders 162 5.2.2.4 NMDA Receptors 162 5.2.2.5 AMPA Receptors 165 5.2.2.6 Kainate Receptors 168 5.2.2.7 Delta Receptors 172 5.2.3 Metabotropic Receptors 173 5.2.3.1 Location 173 5.2.3.2 Effector Mechanisms 174 5.2.3.3 Implication in Neurodisorders 175 5.2.3.4 Structural Features 176 5.3 Glutamate Transporters 184 5.3.1 Implication of Glutamate Transporters in Neurodegeneration 186 5.3.2 Vesicular Glutamate Transporter 1 (VGLUT1) 187 5.3.3 Vesicular Glutamate Transporter 2 (VGLUT2) 187 5.3.4 Vesicular Glutamate Transporter 3 (VGLUT3) 187 References 188 6 The GABAergic System 199 6.1 Introduction 199 6.2 GABA Receptors 201 6.2.1 Classification 201 6.2.2 Location 201 6.2.3 Implication in Neurodegenerative Disorders 204 6.2.4 GABAA Receptors 204 6.2.4.1 Effector Mechanisms 205 6.2.4.2 Structure of Subunits 206 6.2.5 GABAB Receptors 210 6.2.5.1 Effector Mechanisms 210 6.2.5.2 Structure of Receptors 212 6.3 GABA Transporters 213 6.3.1 Vesicular GABA Transporter (VGAT) 216 6.3.2 Betaine Transporter (BGT1) 216 6.3.3 Sodium? and Chloride?Dependent GABA Transporters (GAT1-3) 216 References 218 Part II Metabolism and Proteins 227 7 Metabolism of Neurotransmitters 229 7.1 Introduction 229 7.2 Metabolism of Catecholamines 229 7.2.1 Dopamine 229 7.2.2 Norepinephrine (Noradrenaline) and Epinephrine (Adrenaline) 234 7.3 Metabolism of Serotonin 235 7.4 Metabolism of Acetylcholine 238 7.5 Metabolism of Glutamic Acid and GABA 239 7.5.1 Glutamic Acid 239 7.5.2 ?Aminobutyric Acid (GABA) 240 7.5.3 Neurotransmission Mediated by Glutamic Acid and GABA Metabolisms 240 References 242 8 Enzymes Processing Neurotransmitters 249 8.1 Tyrosine Hydroxylase (TH) 249 8.2 Tryptophan Hydroxylase (Tryptophan?5?monoxygenase, TPH)) 252 8.3 Aromatic Amino Acid Decarboxylase (AADC) 255 8.4 Dopamine ?Hydroxylase (DBH) 257 8.5 Monoamine Oxidase (MAO) 259 8.6 Catecholamine?O?methyl Transferase (COMT) 265 8.7 Phenylethanolamine?N?methyl Transferase (PNMT) 270 8.8 5?Hydroxyindole?O?methyltransferase (HIOMT) 272 8.9 Serotonin?N?acetyl Transferase (SNAT) 274 8.10 Choline Acetyltransferase (ChAT) 274 8.11 Acetylcholinesterase (AChE) 276 8.12 Glutamic Acid Decarboxylase (GAD) 280 8.13 Glutamine Synthetase (GLUL) 281 8.14 GABA Transaminase (GABA?T) 284 References 286 9 Misfolded Proteins 303 9.1 Introduction 303 9.1.1 Amyloid (A ) 304 9.1.2 Tau ( ) 307 9.1.3 ?Synuclein 313 References 316 10 Therapeutic Agents for Neurodegenerative Disorders 325 10.1 Alzheimer’s Disease (AD) 325 10.1.1 Acetylcholinesterase (AChE) Inhibitors 325 10.1.2 Memantine (Namenda (R)) 331 10.2 Parkinson’s Disease (PD) 331 10.2.1 l?DOPA 333 10.2.2 Dopaminergic Agonists 335 10.2.3 MAO?B Inhibitors 340 10.2.4 COMT Inhibitors 343 10.2.5 Amantadine 344 10.3 Lewy Body Disease (LBD) 345 10.4 Huntington’s Disease (HD) 346 10.5 Friedreich’s Ataxia (FA) 346 10.6 Amyotrophic Lateral Sclerosis (ALS) 346 10.7 Spinal Muscular Atrophy (SMA) 347 References 347 Index 359
Trade Policy 买家须知
- 关于产品:
- ● 正版保障:本网站隶属于中国国际图书贸易集团公司,确保所有图书都是100%正版。
- ● 环保纸张:进口图书大多使用的都是环保轻型张,颜色偏黄,重量比较轻。
- ● 毛边版:即书翻页的地方,故意做成了参差不齐的样子,一般为精装版,更具收藏价值。
关于退换货:
- 由于预订产品的特殊性,采购订单正式发订后,买方不得无故取消全部或部分产品的订购。
- 由于进口图书的特殊性,发生以下情况的,请直接拒收货物,由快递返回:
- ● 外包装破损/发错货/少发货/图书外观破损/图书配件不全(例如:光盘等)
并请在工作日通过电话400-008-1110联系我们。
- 签收后,如发生以下情况,请在签收后的5个工作日内联系客服办理退换货:
- ● 缺页/错页/错印/脱线
关于发货时间:
- 一般情况下:
- ●【现货】 下单后48小时内由北京(库房)发出快递。
- ●【预订】【预售】下单后国外发货,到货时间预计5-8周左右,店铺默认中通快递,如需顺丰快递邮费到付。
- ● 需要开具发票的客户,发货时间可能在上述基础上再延后1-2个工作日(紧急发票需求,请联系010-68433105/3213);
- ● 如遇其他特殊原因,对发货时间有影响的,我们会第一时间在网站公告,敬请留意。
关于到货时间:
- 由于进口图书入境入库后,都是委托第三方快递发货,所以我们只能保证在规定时间内发出,但无法为您保证确切的到货时间。
- ● 主要城市一般2-4天
- ● 偏远地区一般4-7天
关于接听咨询电话的时间:
- 010-68433105/3213正常接听咨询电话的时间为:周一至周五上午8:30~下午5:00,周六、日及法定节假日休息,将无法接听来电,敬请谅解。
- 其它时间您也可以通过邮件联系我们:customer@readgo.cn,工作日会优先处理。
关于快递:
- ● 已付款订单:主要由中通、宅急送负责派送,订单进度查询请拨打010-68433105/3213。
本书暂无推荐
本书暂无推荐